What is LOPJLB’s current signal on RLMD?

LOPJLB’s latest quantitative signal on Relmada Therapeutics, Inc. (RLMD) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is RLMD in?

Relmada Therapeutics, Inc. (RLMD) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Relmada Therapeutics, Inc. (RLMD) do?

Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, wh…